MICHAEL SHULTZ,CLAUS EHRHARDT,LESLIE WIGHTON MCQUIRE,PASCAL RIGOLLIER,OLIVIER ROGEL,RUBEN ALBERTO TOMMASI
申请号：
PT09724483
公开号：
PT2268612E
申请日:
2009.03.23
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.
